{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:47:33Z","timestamp":1791863253023,"version":"4.3.4"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20251913"],"award-info":[{"award-number":["BK20251913"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.critrevonc.2026.105638","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:05:49Z","timestamp":1791356749000},"page":"105638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reprogramming the myeloid\u2013T cell ecosystem through engineered oncolytic viruses for durable antitumor immunity"],"prefix":"10.1016","volume":"228","author":[{"given":"Chuanjian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanglu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6372-4765","authenticated-orcid":false,"given":"Yihui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.critrevonc.2026.105638_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ccell.2023.02.001","article-title":"NETworking with cancer: the bidirectional interplay between cancer and neutrophil extracellular traps","volume":"41","author":"Adrover","year":"2023","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105638_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218696","article-title":"VG161 oncolytic virus remodels the tumor microenvironment by expanding CD3(+) macrophages and enhancing antitumor immunity","volume":"657","author":"Bai","year":"2026","journal-title":"Cancer Lett."},{"issue":"92","key":"10.1016\/j.critrevonc.2026.105638_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adg7995","article-title":"Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8(+) T-myeloid cell networks in melanoma","volume":"9","author":"Barras","year":"2024","journal-title":"Sci. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105638_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1189\/jlb.1HI0714-351R","article-title":"Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells","volume":"97","author":"Bigley","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"408","key":"10.1016\/j.critrevonc.2026.105638_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan4220","article-title":"Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs","volume":"9","author":"Brown","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105638_bib6","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.7150\/thno.56494","article-title":"Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105638_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/cas.12537","article-title":"Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer","volume":"105","author":"Chen","year":"2014","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s43018-025-01078-y","article-title":"Genetic engineering of systemically injectable oncolytic viruses for pyroptosis-accelerated cancer virotherapy","volume":"7","author":"Chen","year":"2026","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105638_bib9","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105638_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.794251","article-title":"Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer","volume":"13","author":"Clubb","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41467-023-44576-2","article-title":"Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma","volume":"15","author":"Dai","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105638_bib12","article-title":"Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine","volume":"4","author":"Dan","year":"2023","journal-title":"Cell. Rep. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105638_bib13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.ymthe.2020.02.017","article-title":"Transient inhibition of PI3K\u03b4 enhances the therapeutic effect of intravenous delivery of oncolytic vaccinia virus","volume":"28","author":"Ferguson","year":"2020","journal-title":"Mol. Ther."},{"issue":"21-22","key":"10.1016\/j.critrevonc.2026.105638_bib14","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.vaccine.2003.12.021","article-title":"Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response","volume":"22","author":"Flanagan","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib15","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200264","article-title":"Tumor-infiltrating dendritic cell states are conserved across solid human cancers","volume":"218","author":"Gerhard","year":"2021","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105638_bib16","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/s43018-025-01070-6","article-title":"Retargeted oncolytic viruses engineered to remodel the tumor microenvironment for glioblastoma immunotherapy","volume":"6","author":"Giovannoni","year":"2025","journal-title":"Nat. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105638_bib17","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1078-0432.CCR-12-2733","article-title":"Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells","volume":"19","author":"Guillerme","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12943-024-02140-6","article-title":"Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation","volume":"23","author":"Guo","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-70221-9","article-title":"Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma","volume":"17","author":"Ha","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105638_bib20","article-title":"Spatially organized inflammatory myeloid-CD8(+) T cell aggregates linked to Merkel-cell Polyomavirus driven Reorganization of the Tumor Microenvironment","author":"Haist","year":"2025","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cas.70219","article-title":"Tumor-Derived Prostaglandin E2 Promotes Colorectal Cancer Progression by Inducing N2-Type TAN Polarization","volume":"117","author":"Han","year":"2026","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105638_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010675","article-title":"Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotype","volume":"13","author":"Hatami","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2093054","article-title":"Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation","volume":"11","author":"He","year":"2022","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013550","article-title":"SAMHD1 drives immunosuppression in non-small cell lung cancer by promoting macrophage infiltration and restricting oncolytic adenovirus replication","volume":"14","author":"Hu","year":"2026","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105638_bib25","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.4049\/jimmunol.1700435","article-title":"Oncolytic Reovirus Inhibits Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in a TLR3-Dependent Manner","volume":"200","author":"Katayama","year":"2018","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105638_bib26","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000935","article-title":"Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages","volume":"4","author":"Kemp","year":"2021","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.critrevonc.2026.105638_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1355566","article-title":"Synergistic antitumor immune response mediated by paclitaxel-conjugated nanohybrid oncolytic adenovirus with dendritic cell therapy","volume":"15","author":"Kim","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib28","article-title":"Thymopentin enhances adenoviral oncolytic therapy by regulating macrophages and CD8(+) T cells","volume":"6","author":"Kong","year":"2026","journal-title":"Commun. Med. (Lond. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2096572","article-title":"Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression","volume":"11","author":"Kudling","year":"2022","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105638_bib30","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4049\/jimmunol.166.3.1439","article-title":"Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo","volume":"166","author":"Kurts","year":"2001","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105638_bib31","article-title":"Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas","volume":"6","author":"Labiano","year":"2025","journal-title":"Cell. Rep. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105638_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013175","article-title":"Oncolytic virus-induced IL-1\u03b2(+) monocyte-IL-6(+) CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer","volume":"13","author":"Li","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105638_bib33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1593\/neo.121272","article-title":"Expression of CCL19 from oncolytic vaccinia enhances immunotherapeutic potential while maintaining oncolytic activity","volume":"14","author":"Li","year":"2012","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105638_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-014258","article-title":"Dual-chemokine-armed oncolytic Senecavirus A co-recruits cDC1 and CXCR3(+) T cells to convert 'cold' melanoma and drive durable regression","volume":"14","author":"Li","year":"2026","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105638_bib35","first-page":"263","article-title":"Chronic inflammation-responsive hydrogel restores myeloid-T cell crosstalk to reinvigorate antitumor immunity against metastatic colorectal cancer","volume":"62","author":"Li","year":"2026","journal-title":"Bioact. Mater."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105638_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012858","article-title":"TAMs-mediated resistance to oncolytic virus M1 in solid tumors","volume":"13","author":"Liang","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105638_bib37","article-title":"Thymosin \u03b11 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy","volume":"5","author":"Liu","year":"2024","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.critrevonc.2026.105638_bib38","article-title":"An ICOSL-armed oncolytic adenovirus activates CD4(+) T cell to potentiate antitumor immunity and synergizes with anti-PD-1 or CAR-T cell therapy in colorectal cancer","author":"Liu","year":"2026","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-026-02568-y","article-title":"piR-1170 drives brain metastasis and immune evasion via WTAP-mediated m6A methylation reprogramming in triple-negative breast cancer","volume":"25","author":"Luo","year":"2026","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105638_bib40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","article-title":"Macrophage diversity in cancer revisited in the era of single-cell omics","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.critrevonc.2026.105638_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101481","article-title":"The role of dendritic cells in cancer and anti-tumor immunity","volume":"52","author":"Marciscano","year":"2021","journal-title":"Semin. Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105638_bib42","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.cell.2026.03.025","article-title":"Mapping intratumor heterogeneity across layers for advancing immunotherapy","volume":"189","author":"Marine","year":"2026","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105638_bib43","article-title":"Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer","volume":"7","author":"Mestrallet","year":"2026","journal-title":"Cell. Rep. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105638_bib44","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1039\/D4TB02565B","article-title":"Decomposable STING nanoagonist-amplified oncolytic virotherapy through remodeling the immunosuppressive microenvironment of triple-negative breast cancer","volume":"13","author":"Mu","year":"2025","journal-title":"J. Mater. Chem. B"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105638_bib45","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","article-title":"Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease","volume":"54","author":"Mulder","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013640","article-title":"CD73 blockade enhances antitumor efficacy of oHSV in solid tumors by increasing macrophage-mediated antigen presentation","volume":"14","author":"Murphy","year":"2026","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib47","article-title":"Oncolytic adenovirus inhibits TNBC tumor growth\/metastasis in mice by targeting TGF-\u03b2 and overexpressing GM-CSF","volume":"33","author":"Nh\u00e0n","year":"2025","journal-title":"Mol. Ther. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105638_bib48","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105638_bib49","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.ccell.2025.06.006","article-title":"A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesis","volume":"43","author":"Qian","year":"2025","journal-title":"Cancer Cell."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105638_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012138","article-title":"Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy","volume":"13","author":"Russo","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"233","key":"10.1016\/j.critrevonc.2026.105638_bib51","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2025.0481","article-title":"Mathematical modelling of oncolytic vaccinia virus therapy highlights neutrophil impact on tumour suppression","volume":"22","author":"Satani","year":"2025","journal-title":"J. R. Soc. Interface"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105638_bib52","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1158\/1078-0432.CCR-19-3231","article-title":"Single-Cell Genomic Characterization Reveals the Cellular Reprogramming of the Gastric Tumor Microenvironment","volume":"26","author":"Sathe","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105638_bib53","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.medj.2024.03.015","article-title":"Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanoma","volume":"5","author":"Schlenker","year":"2024","journal-title":"Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105638_bib54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2023.12.011","article-title":"Bispecific dendritic-T cell engager potentiates anti-tumor immunity","volume":"187","author":"Shapir Itai","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib55","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41392-025-02511-5","article-title":"Oncolytic adenovirus delivery of neoantigens sensitizes low-mutation tumors to anti-PD-1 therapy and prevents metastasis","volume":"10","author":"Shen","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib56","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymthe.2018.11.010","article-title":"Modulating the tumor microenvironment via oncolytic viruses and CSF-1R inhibition synergistically enhances anti-PD-1 Immunotherapy","volume":"27","author":"Shi","year":"2019","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105638_bib57","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/1878-0261.13603","article-title":"STING activator 2\u20323'-cGAMP enhanced HSV-1-based oncolytic viral therapy","volume":"18","author":"Sibal","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105638_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114514","article-title":"Escherichia coli Nissle 1917 outer membrane vesicles encapsulating oncolytic virus remodel tumor-associated macrophages and kill prostate cancer cells","volume":"390","author":"Sun","year":"2026","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib59","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1038\/s41467-022-34791-8","article-title":"Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity","volume":"13","author":"Svensson-Arvelund","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105638_bib60","article-title":"Induced pluripotent stem cell-derived dendritic cells potentiate the efficacy of interleukin-12-expressing oncolytic HSV-1","volume":"34","author":"Taguchi","year":"2026","journal-title":"Mol. Ther. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105638_bib61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/jleuko\/qiad150","article-title":"Enhancing the efficacy of vaccinia-based oncolytic virotherapy by inhibiting CXCR2-mediated MDSC trafficking","volume":"115","author":"Tan","year":"2024","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105638_bib62","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105638_bib63","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1158\/1535-7163.MCT-23-0873","article-title":"Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time Dependent","volume":"23","author":"Totsch","year":"2024","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105638_bib64","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ccell.2024.04.011","article-title":"Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy","volume":"42","author":"van Elsas","year":"2024","journal-title":"Cancer Cell."},{"issue":"25","key":"10.1016\/j.critrevonc.2026.105638_bib65","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1016\/j.cell.2025.10.030","article-title":"Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy","volume":"188","author":"von Locquenghien","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105638_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1304374","article-title":"YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells","volume":"14","author":"von Ofen","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib67","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Waibl Polania","year":"2025","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105638_bib68","article-title":"Engineered oncolytic virus OH2-FLT3L enhances antitumor immunity via dendritic cell activation","volume":"33","author":"Wan","year":"2025","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105638_bib69","article-title":"CD300ld on pathologically activated neutrophils promotes tumor immune suppression by binding phosphatidylserine on CD8(+) T cells","author":"Wang","year":"2026","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105638_bib70","article-title":"Engineering Oncolytic Virus-Armed Macrophages for Enhanced Cancer Immunotherapy","author":"Wang","year":"2026","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib71","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13046-025-03358-y","article-title":"Viral expression of NE\/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory\/effector CD8(+) T cell infiltration","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105638_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008431","article-title":"An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib73","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1038\/s41467-023-39683-z","article-title":"Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105638_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01555-w","article-title":"HBsAg-tagged tumour vaccine system eliminates solid tumours through virus-specific memory T cells","author":"Wang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105638_bib75","doi-asserted-by":"crossref","first-page":"9784","DOI":"10.1021\/acsnano.5c19047","article-title":"Triple-Cascade Responsive Pneumatic Nanomotor Enhance Cancer Immunotherapy by Oncolytic Virus-Triggered Pyroptosis","volume":"20","author":"Wang","year":"2026","journal-title":"ACS Nano"},{"issue":"89","key":"10.1016\/j.critrevonc.2026.105638_bib76","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adj5097","article-title":"Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1","volume":"8","author":"Wattenberg","year":"2023","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib77","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12967-023-04374-2","article-title":"Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models","volume":"21","author":"Wenthe","year":"2023","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105638_bib78","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-026-04396-x","article-title":"IL-18-armed oncolytic vaccinia virus remodels the suppressive microenvironment via macrophage and Treg modulation in lymphoma","volume":"75","author":"Wu","year":"2026","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105638_bib79","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41423-025-01260-3","article-title":"GLP1 alleviates oleic acid-propelled lipocalin-2 generation by tumor-infiltrating CD8(+)\u2009T cells to reduce polymorphonuclear MDSC recruitment and enhances viral immunotherapy in pancreatic cancer","volume":"22","author":"Wu","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105638_bib80","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","article-title":"Neutrophil profiling illuminates anti-tumor antigen-presenting potency","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib81","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41541-025-01219-5","article-title":"Oncolytic virus-mediated p53 activation boosts the antitumor immunity of a p53-transduced dendritic cell vaccine","volume":"10","author":"Yamada","year":"2025","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.critrevonc.2026.105638_bib82","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.omto.2021.01.016","article-title":"Oncolytic vaccinia virus induces a novel phenotype of CD8(+) effector T cells characterized by high ICOS expression","volume":"20","author":"Yamashita","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105638_bib83","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/pros.22914","article-title":"Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes","volume":"75","author":"Yan","year":"2015","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105638_bib84","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41551-025-01569-4","article-title":"A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity","volume":"10","author":"Yang","year":"2026","journal-title":"Nat. Biomed. Eng."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105638_bib85","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s00262-021-02860-4","article-title":"IL-36\u03b3-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity","volume":"70","author":"Yang","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105638_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16051021","article-title":"Intratumoral Delivery of Interleukin 9 via Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in Tumor Models","volume":"16","author":"Ye","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib87","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s13046-025-03596-0","article-title":"TIM-3 blockade reverses oncolytic vaccinia virus-induced DCs inactivation and T cells exhaustion to improve antitumor immunity and therapeutic efficacy","volume":"44","author":"Ye","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib88","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/s41467-026-69456-3","article-title":"Triple targeting of STING, TGF-\u03b2, and PD-L1 boosts CXCL16-CXCR6 signaling for potent antitumor response","volume":"17","author":"Yi","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105638_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.728169","article-title":"A dynamic transcriptome map of different tissue microenvironment cells identified during gastric cancer development using single-cell rna sequencing","volume":"12","author":"Yin","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105638_bib90","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.immuni.2013.03.004","article-title":"Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-\u03b2","volume":"38","author":"Yu","year":"2013","journal-title":"Immunity"},{"issue":"3-4","key":"10.1016\/j.critrevonc.2026.105638_bib91","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1089\/hum.2020.222","article-title":"Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient Samples","volume":"32","author":"Zafar","year":"2021","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib92","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13740","article-title":"Oncolytic herpes simplex virus propagates tertiary lymphoid structure formation via CXCL10\/CXCR3 to boost antitumor immunity","volume":"58","author":"Zhang","year":"2025","journal-title":"Cell. Prolif."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105638_bib93","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1016\/j.celrep.2020.03.020","article-title":"Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer","volume":"30","author":"Zhang","year":"2020","journal-title":"Cell. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib94","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1038\/s41467-021-27018-9","article-title":"Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib95","article-title":"Reactivating exhausted tumor-infiltrating T cells by a bispecific DC-T cell engager in mice","volume":"17","author":"Zhang","year":"2026","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105638_bib96","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010767","article-title":"Targeted release of a bispecific fusion protein SIRP\u03b1\/Siglec-10 by oncolytic adenovirus reinvigorates tumor-associated macrophages to improve therapeutic outcomes in solid tumors","volume":"13","author":"Zhang","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105638_bib97","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4049\/jimmunol.1102262","article-title":"Attenuated, oncolytic, but not wild-type measles virus infection has pleiotropic effects on human neutrophil function","volume":"188","author":"Zhang","year":"2012","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105638_bib98","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41388-026-03685-0","article-title":"Synergistic reprogramming of the tumor immune microenvironment by Senecavirus A and STING agonist","volume":"45","author":"Zhao","year":"2026","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105638_bib99","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1021\/acs.molpharmaceut.2c00407","article-title":"Immune-cell-derived exosomes for cancer therapy","volume":"19","author":"Zhao","year":"2022","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105638_bib100","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/cas.16105","article-title":"Transient inhibition of neutrophil functions enhances the antitumor effect of intravenously delivered oncolytic vaccinia virus","volume":"115","author":"Zhou","year":"2024","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105638_bib101","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/s41467-020-20059-6","article-title":"Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:22:03Z","timestamp":1791861723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826005251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":101,"alternative-id":["S1040842826005251"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105638","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming the myeloid\u2013T cell ecosystem through engineered oncolytic viruses for durable antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105638"}}